Skip Page Header

Home > National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn.

New South Wales Department of Health. (2006) National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn. Sydney: New South Wales Department of Health.

[img]
Preview
PDF - Published Version
1MB

These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families. They have been developed through a process based on evidence reviews and expert consensus. The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.

Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.


Date
2006
Call No
EE20.4.2, MP18, VK
Pages
x ,101
Publisher
New South Wales Department of Health
Corporate Creators
New South Wales Department of Health
Place of Publication
Sydney
ISBN
0 7347 3890 0
Keywords
AOD use, Australia, birth, breast feeding, clinical guide, harm reduction, infant, mother, postnatal care, pregnancy, prenatal care, risk management
Notes
Includes appendices, bibliographcial references and a glossary.
EndNote
Accession Number
HRB 3795 (Available)

Repository Staff Only: item control page